cushion stock?, page-2

re: medical breakthrough-good news
Maybe this news has something to do with the price hike.....
Shares in medical research company Biota leapt more than 30 per cent on opening on Wednesday, after the company announced a medical breakthrough in its in program to develop a drug to combat HIV/AIDS. Biota has developed its proprietary N-MAX technology, which create nucleoside drugs able to operate at enhanced levels of activity with reduced toxicity. A previously developed nucleoside drug, AZT, is a leading anti-HIV treatment with sales of about $1.5 billion worldwide has been a primary target for the Biota research. "The AZT-mimic research has been a remarkable success," Biota Group chief executive Peter Molloy said. "In less than a year, [president and chief scientist] Dan Cook's scientific team has demonstrated proof-of-concept for the N-MAX technology and discovered a series of novel compounds that could lead to new treatments for HIV/AIDS." The lead compound series, B-109, is covered by Biota-filed patents. Biota shares were up 28.4 per cent, or 13.5¢, at 61¢.